Literature DB >> 5954309

Delayed transitory clinical manifestations after radiation treatment of intracranial tumors.

E Boldrey, G Sheline.   

Abstract

Entities:  

Mesh:

Year:  1966        PMID: 5954309     DOI: 10.3109/02841856609139537

Source DB:  PubMed          Journal:  Acta Radiol Ther Phys Biol        ISSN: 0567-8064


× No keyword cloud information.
  8 in total

1.  Radiotherapy in the management of temporal bone chemodectoma.

Authors:  W M Mendenhall; J T Parsons; S P Stringer; N J Cassisi; G T Singleton; R R Million
Journal:  Skull Base Surg       Date:  1995

2.  Status spongiosus in the course of treatment of malignant gliomas.

Authors:  M Poisson; J J Hauw; R Mashaly; C Duyckaerts; R Escourolle
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

3.  Comprehensive assessment of Somnolence Syndrome in patients undergoing radiation to the brain.

Authors:  Ritika R Harjani; Janaki Manur Gururajachar; Umamaheswari Krishnaswamy
Journal:  Rep Pract Oncol Radiother       Date:  2016-09-29

4.  Complications of Radiotherapy and Radiosurgery in the Brain and Spine.

Authors:  G Barisano; S Bergamaschi; J Acharya; A Rajamohan; W Gibbs; P Kim; G Zada; E Chang; M Law
Journal:  Neurographics (2011)       Date:  2018-06

5.  Histologic evidence of a radiosensitizing effect of Taxol in patients with astrocytomas.

Authors:  T Wehbe; M Glantz; H Choy; L Glantz; S Cortez; W Akerley; P Mills; B Cole
Journal:  J Neurooncol       Date:  1998-09       Impact factor: 4.130

6.  Early-delayed radiation rhombencephalopathy.

Authors:  S Nightingale; P J Dawes; N E Cartlidge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-03       Impact factor: 10.154

7.  Somnolence after prophylactic cranial irradiation in children with acute lymphoblastic leukaemia.

Authors:  J E Freeman; P G Johnston; J M Voke
Journal:  Br Med J       Date:  1973-12-01

Review 8.  Standard and novel radiotherapeutic approaches to neoplastic meningitis.

Authors:  Eric L Chang; Moshe H Maor
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.